Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase Ⅰb Study
Clinical trial NCT05586841 · COMPLETED
Trial details
- NCT number
- NCT05586841
- Sponsor
- Beijing 302 Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2025-12-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.